Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

1. Cisterna, R.
2. Tellería, O.
3. Hernaez, S.
4. Ezpeleta, G.

Esportatu

Esportatu

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Esportatu

×

Dokumentua ezin da beste atari batetik esportatu.

Testu osoa

lock_openTestu osoa externo

DOI: 10.4137/CMT.S8293 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

• 

Datuen iturria: Scopus